Ireland
--:--IST
Active, not recruiting Not applicable

Cooperation for Primary Care Patients on Sick Leave for CMD: Care Manager and Workplace Intervention - CO-WORK-CARE

NCT03250026 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2017-12-05
Last updated
2025-04-11

Condition(s) studied

Depressive DisorderAnxiety Disorders

Investigational drug(s) / intervention(s)

Workplace convergence dialogueCare Manager

Workplace convergence dialogue: Work place contact as a convergence dialogue between the employer and employee with the Rehab Coordinator as a guide

Care Manager: Regular contact Care Manager during around 12 weeks

Study summary

This study aims to evaluate whether a convergence dialogue during sick leave, between the employee and the employer, with the Primary Care Centre Rehab Coordinator as discussion leader, leads to reduced sick leave time compared to those individuals who only have contact with a Care Manager during the period of sick leave. The study will be performed as a randomised controlled trial with randomisation at the PCC level where intervention PCCs offers a convergence dialogue meeting with the work place representative during sick leave in addition to Care Manager contact.

Eligibility

Sex
ALL
Min age
18 Years
Max age
67 Years
Healthy volunteers
No
Inclusion Criteria: Patients attending primary care centers with care manager function * aged \>=18 to 67 years * diagnosed with a new (\< 1 month) depression diagnose (F32, F33), anxiety syndrome (F41, F48) or stress related adjustment disorder (F43) * on sick-leave \> 14 days Exclusion Criteria: * Bipolar disorder * psychosis * addiction * other serious mental disorder * suicidal ideation or earlier suicide attempt * cognitive impairment or not speaking/understanding Swedish

Primary outcome measure(s)

  • Net and gross sick-leave days — 12 months
    number of net and gross sick-leave days during 12 months

Trial sites (1)

FacilityCityRegionStatus
Department of Primary Health Care, Sahlgrenska Academy Gothenburg Region Västra Götaland
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03250026 on ClinicalTrials.gov ↗ ← All trials in Sweden